Blood Collection Market to Reach USD 10.90 Billion by 2022September 22nd, 2017
Sysmex CA-540 - An Ideal Analyzer for Clinical LaboratoriesSeptember 20th, 2017
MEDICA 2017 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3D35-2
69th AACC Annual Meeting and Clinical Lab Expo - July 30 - August 3, 2017
SAN DIEGO, CA, USA
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
The retroviruses HIV-1 and HIV-2 are known to be causative agents of the Acquired Immunodeficiency Syndrome (AIDS). Both retroviruses are transmitted mainly through sexual intercourse or through contact with blood and blood products as well as diaplacentally from pregnant women to their babies.
More than 90 % of infected individuals develop antibodies to different proteins of HIV within a period of 3 to 6 weeks after infection. A short viraemic phase precedes seroconversion, in which p24 antigen is detectable by highly sensitive assays. From that point of time genomically integrated viral DNA can also be detected in mononuclear blood cells by polymerase chain reaction.
However, the method of choice for screening of HIV infections is the detection of antibodies to HIV by enzyme immunoassay.